MITF and melanoma: However, another study found that AXL is not necessary for intrinsic resistance maintenance and suggested that the reduced expression of melanocyte inducing transcription factor (MITF) and the overexpression of nuclear factor kappa B (NF-κB) may moderate melanoma resistance to mitogen-activated protein kinase (MAPK) pathway inhibitors (87).